# Targeted Potassium Levels for Prevention of ICD Therapy

Study · id `cardio:ct-nct03833089` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03833089](<https://clinicaltrials.gov/study/NCT03833089>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03833089

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1200 participants.

## Technical summary

Registry record NCT03833089. Randomized; no masking; primary purpose prevention. Start 2019-03-01 (actual); primary completion 2025-05-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 1200 participants (planned count; ClinicalTrials.gov record NCT03833089, source copy `cardio:ctgov-nct03833089-2025-05-09`, retrieved 2026-10-26)
- Started: 2019-03-01 (actual) (ClinicalTrials.gov record NCT03833089, source copy `cardio:ctgov-nct03833089-2025-05-09`, retrieved 2026-10-26)
- Primary completion: 2025-05-09 (anticipated) (ClinicalTrials.gov record NCT03833089, source copy `cardio:ctgov-nct03833089-2025-05-09`, retrieved 2026-10-26)
- Completion: 2035-04-01 (anticipated) (ClinicalTrials.gov record NCT03833089, source copy `cardio:ctgov-nct03833089-2025-05-09`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT03833089, source copy `cardio:ctgov-nct03833089-2025-05-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03833089-2025-05-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Targeted Potassium Levels for Prevention of ICD Therapy
- Condition: Ventricular Arrhythmias and Cardiac Arrest
- Condition: Implantable Defibrillator User
- Condition: Hypokalemia
- Condition: Hyperkalemia
- Condition: Ventricular Tachycardia
- Condition: Atrial Fibrillation
- Intervention (Combination product): Targeted serum potassium level
- Lead sponsor: Copenhagen University Hospital, Rigshospitalet
- Lead sponsor class: OTHER
- Collaborator: Herlev and Gentofte Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)
- Registry lists this organization as the lead sponsor: Copenhagen University Hospital, Rigshospitalet (`cardio:org-copenhagen-university-hospital-rigshospitalet`)
- Registry lists this organization as a collaborator: Herlev and Gentofte Hospital (`cardio:org-herlev-and-gentofte-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias (`cardio:pubmed-40879429`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: daea5cd22f50ca8b0bbf32b3dbec82410f4dd04daac38060e4738db46e72ef13
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
